课题基金 / 基金详情

项目摘要

项目成果

MARC L REITMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background Type 2 diabetes mellitus (T2DM) is a condition characterized by insulin resistance and progressive failure of the insulin-secreting beta-cells. Based on studies in small cohorts of young patients (especially Pima Indian offspring), we know that individuals with childhood onset T2DM are at very high risk for diabetes-related morbidity and mortality, due to a longer life-time duration of diabetes, as well as possible faster progression of beta-cell failure. Based on the currently largest available interventional trial, the TODAY study (Treatment Options for Diabetes in Adolescents and Youth), we know that standard medical treatment (metformin) is prone to fail in most patients. Our primary study objective is to acquire data on the natural history of T2DM in youth. Measurements will include indices of beta-cell function, body composition, cardiovascular disease risk factors, gut hormones, and psychological well-being. These data will be compared to findings in non-diabetic volunteers who are lean or overweight/obese. The study will also allow us to collaborate with other investigators in order to investigate factors (e.g. body composition changes, effect of life-style changes (such as sleep)) that determine the progression to and outcome of type 2 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF GENE EXPRESSION RELEVANT TO THE ADIPOSE CELL AND OBESITY
Physiology and Pharmacology of BRS-3 (Bombesin Receptor Subtype-3)
Studies in Youths & Young Adults with Obesity & T2DM (07-DK-0115, 10-DK-0163)
Physiology and Pharmacology of BRS3 (Bombesin-Like Receptor 3)
海外基金